Skip to content
Sonic
AI
Sonic
AI
Home
Discover
Ask Sonic
Projects
Use with Claude or ChatGPT
Show me around
Request source or feature
Dr. Carina Kern, Sonic AI
Home
/
Discover
/
Dr. Carina Kern
D
Dr. Carina Kern
Person
2
Mentions
Episodes
2
Claims
Claims
By Source
Timeline
All
(2)
Business
(0)
Healthcare
(2)
Government
(0)
Tech
(0)
Energy
(0)
Science
(0)
Geopolitics
(0)
Linkgevity plans to conduct its initial clinical trial for its anti-necrosis drug in kidney disease, which serves as an accelerated aging model.
Expert perspective
Dr. Karina Kern
Jun 2
Linkgevity has developed a first-in-class drug designed to inhibit necrosis, a form of negative cell death that underlies tissue degeneration.
Expert perspective
Dr. Karina Kern
Jun 2
Sign up free to see the full entity analysis
Get started free
Back to Entities
Entity Detail